Literature DB >> 7615867

p53 in human papillomavirus associated anogenital cancers.

K Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615867      PMCID： PMC502566          DOI： 10.1136/jcp.48.4.393-a

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

4.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; J H Smith; S V Polacarz; K Rogers; F Sharp
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

5.  p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration.

Authors:  K Cooper; C S Herrington; M F Evans; K C Gatter; J O McGee
Journal:  J Pathol       Date:  1993-09       Impact factor: 7.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.